CCS

Company in Canada

Share this profile

Resume
Canadian Cardiovascular Society Awarded $1.4M to Continue Important National Study of COVID-19 and mRNA Vaccines - Canadian Cardiovascular Society
Finance

 2023 Annual Report
Annual Report
3 pages
| Annual Report

Social Network

  last updated on